Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Nov 07, 2026
TickeronGET DAILY SIGNALS
Fidelity Small-Mid Multifactor ETF (FSMD): Recent Performance and 2026 Considerations

Fidelity Small-Mid Multifactor ETF (FSMD): Recent Performance and 2026 Considerations

Key Takeaways

  • FSMD tracks the Fidelity Small-Mid Multifactor Index, a passively managed, rules-based strategy that tilts toward U.S. small- and mid-capitalization stocks with attractive valuations, quality, momentum, and lower volatility.
  • The fund is highly diversified, holding roughly 600 securities with no single position representing more than about 1% of assets; the top 10 holdings account for only about 4.5% of the portfolio.
  • Sector exposure is led by Industrials at roughly 20% of assets, followed by Financials and Information Technology in the mid-teens, with Health Care and Consumer Discretionary in the low teens.
  • Over the trailing 30 days the ETF has edged lower by about 1.5%, while it is down roughly 6.5% over the trailing quarter after reaching a 52-week high near $53 in mid-August.
  • With a net expense ratio of 0.15% and approximately $2.5 billion in assets under management (AUM), FSMD functions as a low-cost core small/mid-cap allocation.
  • For deeper research, review this ticker's Price Targets and Forecast on additional pages to complement this ETF analysis.
  • Explore Trending AI Robots to see algorithm-driven strategies actively scanning the market.

FSMD ETF Overview

The FSMD seeks to provide investment returns that correspond, before fees and expenses, to the performance of the Fidelity Small-Mid Multifactor Index. The index is designed to reflect the performance of small- and mid-cap U.S. companies with attractive valuations, high-quality profiles, positive momentum signals, and lower volatility than the broader market. Launched in 2019 and sub-advised by Geode Capital Management, the fund is passively managed and rules-based rather than actively or thematically driven.

The portfolio holds roughly 600 securities, a structure that spreads risk across a broad cross-section of the small- and mid-cap universe. Its largest sector allocation is Industrials at approximately 20% of assets, followed by Financials and Information Technology in the mid-teens. Health Care and Consumer Discretionary each contribute roughly 11% to 12%, with smaller weights in Real Estate, Materials, Communication Services, Consumer Staples, Energy, and Utilities. The fund's net expense ratio is 0.15%, which is well below the average for the small-cap blend category. I also checked this using Tickeron’s AI Screener to see how the fund compares to others in the category.

Industry and Thematic Landscape

Small- and mid-cap equities are structurally more sensitive than large caps to shifts in interest rates, credit conditions, and the domestic economic cycle. Because these companies often carry a higher share of floating-rate or refinanceable debt and derive a greater proportion of revenue from U.S. demand, they tend to respond more visibly to changes in monetary policy expectations and inflation data. The multifactor framework underlying FSMD adds another dimension: rather than holding the broad market, the index overweights stocks that score well on valuation, quality, and momentum while dampening exposure to higher-volatility names.

This tilts the fund toward established, cash-generative businesses within cyclical sectors such as Industrials and Financials, while reducing concentration in the largest technology names that dominate capitalization-weighted indexes. As a result, FSMD's performance profile tends to diverge from large-cap benchmarks and can be influenced by sector rotation, regional-bank sentiment, industrial activity, and credit spreads rather than by a handful of mega-cap stocks.

Performance and Positioning Snapshot

FSMD has pulled back modestly over recent weeks and more notably over the trailing quarter. From a level near $49.70 about 30 days earlier, the fund traded to roughly $48.99, a decline of approximately 1.5%. Over the trailing three months, the decline is larger: the fund closed near $52.38 at the start of the period before easing to its current level, a move of roughly 6.5%. The fund reached a 52-week high near $53 in mid-August before drifting lower through September and October, with a sharp single-session pullback in early November.

The gradual, range-bound decline reflects a market environment in which economically sensitive small- and mid-cap segments have lagged. Industrials and Financials, the fund's largest sector exposures, are closely tied to expectations for economic growth and interest rates, and these areas have experienced uneven performance as investors weigh the pace of policy easing against the durability of economic expansion. Because the portfolio is so diversified, no single holding has driven the move; instead, the modest drawdown reflects broad sector-level pressure rather than idiosyncratic weakness in any one position. From what I see, this positioning makes the fund worth monitoring closely in the current environment.

2026 Outlook and Key Factors to Monitor

Several structural factors are likely to shape FSMD's trajectory through 2026. The path of interest rates and inflation will remain central, as small- and mid-cap equities are sensitive to borrowing costs and credit availability. Sustained disinflation and a measured easing cycle could support the Financials and cyclical Industrials that dominate the fund, while a reacceleration in inflation could pressure valuations. The earnings cycle of the fund's major holdings—concentrated in industrials, regional banks, and technology hardware—will also matter, as will the pace of capital expenditure and business investment.

Investors should monitor sector rotation, institutional fund flows into small- and mid-cap strategies, and any policy or regulatory developments affecting credit markets and regional banks. ETF competition within the multifactor space remains a consideration, though FSMD's low fee and diversified structure position it competitively. Risks include slower-than-expected economic growth, tightening financial conditions, and a potential shift in investor preference back toward large-cap growth. These themes, rather than any single event, are likely to define the fund's behavior in the months ahead.

AI Tools in My Research Process

I frequently turn to Tickeron’s AI Screener when evaluating ETFs like this one. The platform lets me quickly scan for comparable funds using technical indicators, fundamentals, and AI-generated signals, which helps refine my watchlist and spot potential additions or adjustments without spending hours on manual reviews. It has become a practical part of how I cross-check sector exposures and performance characteristics in real time.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: FSMD

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


FSMD in upward trend: price may ascend as a result of having broken its lower Bollinger Band on November 05, 2026

FSMD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 33 of 35 cases where FSMD's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where FSMD's RSI Oscillator exited the oversold zone, 25 of 28 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 89%.

The 10-day moving average for FSMD crossed bullishly above the 50-day moving average on November 03, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 13 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 87%.

Following a +1.03% 3-day Advance, the price is estimated to grow further. Considering data from situations where FSMD advanced for three days, in 247 of 297 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.

The Aroon Indicator entered an Uptrend today. In 222 of 279 cases where FSMD Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 80%.

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 59 of 70 cases where FSMD's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 84%.

The Momentum Indicator moved below the 0 level on November 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on FSMD as a result. In 72 of 94 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 77%.

The Moving Average Convergence Divergence Histogram (MACD) for FSMD turned negative on November 05, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In 39 of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at 83%.

FSMD moved below its 50-day moving average on November 05, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where FSMD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 80%.

Notable companies

The most notable companies in this group are Incyte Corp (NASDAQ:INCY), Guardant Health (NASDAQ:GH), Exelixis (NASDAQ:EXEL), Nutanix (NASDAQ:NTNX), APA Corp (NASDAQ:APA), Lattice Semiconductor Corp (NASDAQ:LSCC), Five Below (NASDAQ:FIVE), Elanco Animal Health (NYSE:ELAN), Skyworks Solutions (NASDAQ:SWKS), DaVita (NYSE:DVA).

Industry description

The investment seeks to provide investment returns that correspond, before fees and expenses, generally to the performance of the Fidelity Small-Mid Multifactor Index℠. The fund normally invests at least 80% of its assets in securities included in the Fidelity Small-Mid Multifactor Index℠, which is designed to reflect the performance of stocks of small- and mid-capitalization U.S. companies with attractive valuations, high quality profiles, positive momentum signals, and lower volatility than the broader market, as represented by the Fidelity U.S. Extended Investable Market Index℠.

Market Cap

The average market capitalization across the Fidelity Small-Mid Multifactor ETF (FSMD) ETF is 6.72B. The market cap for tickers in the group ranges from 194.72M to 39.07B. VIK holds the highest valuation in this group at 39.07B. The lowest valued company is ANIK at 194.72M.

High and low price notable news

The average weekly price growth across all stocks in the Fidelity Small-Mid Multifactor ETF (FSMD) ETF was -3%. For the same ETF, the average monthly price growth was -1%, and the average quarterly price growth was -1%. VCEL experienced the highest price growth at 36%, while DOX experienced the biggest fall at -33%.

Volume

The average weekly volume growth across all stocks in the Fidelity Small-Mid Multifactor ETF (FSMD) ETF was -1%. For the same stocks of the ETF, the average monthly volume growth was 18% and the average quarterly volume growth was -14%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 64
P/E Growth Rating: 52
Price Growth Rating: 50
SMR Rating: 55
Profit Risk Rating: 60
Seasonality Score: 11 (-100 ... +100)
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Category SmallBlend

Category
Small Blend
Address
82 Devonshire StreetBoston
Phone
N/A
Web
www.institutional.fidelity.com
Interact to see
Advertisement
The Bitwise Solana Staking ETF (BSOL) advanced roughly 18% over the trailing 30 days, closely tracking a sharp rally in Solana (SOL). The move extends a broader recovery, with BSOL up approximately 77% over the past three months from its mid-2026 trough.
MSTY is an actively managed single-stock option income ETF (exchange-traded fund) that writes call options on Strategy (MSTR), formerly MicroStrategy, to generate current income. The portfolio is anchored by U.S. Treasury bills and MSTR option contracts rather than a diversified basket of equities, concentrating exposure in one volatile underlying.
AMDL has surged roughly +64% over the past 30 days, from about $47.59 to $78.10, mirroring a powerful rally in its sole underlying stock, AMD . The fund is a leveraged single-stock ETF (exchange-traded fund) designed to deliver 2x the daily return of AMD, amplifying both gains and losses.
Analysts expect Q1 2026 revenue of $1.54 billion, reflecting approximately 74% year-over-year growth. Consensus earnings per share (EPS) forecast stands at $0.28, up over 115% from the prior year.
Analysts expect Q1 2026 revenue of $3.00 billion, up 8% from $2.77 billion in the year-ago quarter. Consensus earnings per share (EPS) estimate stands at $4.31, reflecting steady profitability from the cystic fibrosis (CF) portfolio.